Replies to post #2214 on Akers Biosciences Inc. (AKER)

[SeanVan]

MyMD Pharmaceuticals Begins Trading on Nasdaq..
.
FLASH... FLASH... Phase II Trial results expected by year end
.
“The listing of our shares on the Nasdaq marks a significant milestone for the company, in combination with our upcoming phase II trial and our clinical development pipeline, all of which should lead to increased visibility in the near term for our investors..
.
https://www.businesswire.com/news/home/20210419005502/en/MyMD-Pharmaceuticals-Begins-Trading-on-Nasdaq